The use of lipid-based nanocarriers for targeted pain therapies.

Front Pharmacol · 2013 · PMC3836271 · PMID 24319430

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These targeted nanoparticles produced highly significant analgesic and anti-inflammatory effects over the 48-h time course studied following intravenous administration in rats with Complete Freund’s Adjuvant-induced inflammation of the paw.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.